QPharma launches Neolytica for AI-focused analytics

By The Science Advisory Board staff writers

June 9, 2021 -- QPharma has launched Neolytica, a new subsidiary focused on artificial intelligence (AI) for healthcare analytics.

QPharma's move to invest in data analytics and AI meshes well with the company's expertise in the pharmaceutical industry, in particular key opinion leader (KOL) mapping and healthcare professional (HCP) targeting. Neolytica's analytical solutions will use next-generation technologies like natural language processing, AI, face recognition, and chatbots.

Neolytica will focus its efforts on the use of AI in medical affairs, market access, commercial marketing, and commercial sales, according to the company.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.